Your browser doesn't support javascript.
loading
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.
Willeit, Peter; Skroblin, Philipp; Moschen, Alexander R; Yin, Xiaoke; Kaudewitz, Dorothee; Zampetaki, Anna; Barwari, Temo; Whitehead, Meredith; Ramírez, Cristina M; Goedeke, Leigh; Rotllan, Noemi; Bonora, Enzo; Hughes, Alun D; Santer, Peter; Fernández-Hernando, Carlos; Tilg, Herbert; Willeit, Johann; Kiechl, Stefan; Mayr, Manuel.
Afiliação
  • Willeit P; King's British Heart Foundation Centre, King's College London, London, U.K. peter.willeit@i-med.ac.at manuel.mayr@kcl.ac.uk.
  • Skroblin P; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Moschen AR; Department of Public Health and Primary Care, University of Cambridge, Cambridge, U.K.
  • Yin X; King's British Heart Foundation Centre, King's College London, London, U.K.
  • Kaudewitz D; Department of Internal Medicine I (Endocrinology, Gastroenterology and Metabolic Diseases), Medical University of Innsbruck, Innsbruck, Austria.
  • Zampetaki A; King's British Heart Foundation Centre, King's College London, London, U.K.
  • Barwari T; King's British Heart Foundation Centre, King's College London, London, U.K.
  • Whitehead M; King's British Heart Foundation Centre, King's College London, London, U.K.
  • Ramírez CM; King's British Heart Foundation Centre, King's College London, London, U.K.
  • Goedeke L; King's British Heart Foundation Centre, King's College London, London, U.K.
  • Rotllan N; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT.
  • Bonora E; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT.
  • Hughes AD; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT.
  • Santer P; Division of Endocrinology, Diabetes, and Metabolic Diseases, University and Hospital Trust of Verona, Verona, Italy.
  • Fernández-Hernando C; Institute of Cardiovascular Sciences, University College London, London, U.K.
  • Tilg H; Department of Laboratory Medicine, Bruneck Hospital, Bruneck, Italy.
  • Willeit J; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT.
  • Kiechl S; Department of Internal Medicine I (Endocrinology, Gastroenterology and Metabolic Diseases), Medical University of Innsbruck, Innsbruck, Austria.
  • Mayr M; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Diabetes ; 66(2): 347-357, 2017 02.
Article em En | MEDLINE | ID: mdl-27899485
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / MicroRNAs / Diabetes Mellitus Tipo 2 / Dislipidemias / Obesidade Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / MicroRNAs / Diabetes Mellitus Tipo 2 / Dislipidemias / Obesidade Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article